Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Sheng, Li ^a   Cao, Wenjie ^a   Cha, Bingbing ^a   Chen, Zhaoping ^a   Wang, Fang ^a   Liu, Jun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Carotid atherosclerotic plaques; Intima media thickness; Osteocalcin

Indexed keywords

ADIPONECTIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); DISEASE DURATION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; RADIOIMMUNOASSAY; RISK ASSESSMENT;

AGED; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN;

EID: 84872504176     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-22     Document Type: Article

References (35)

1. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997, 96:1432-1437. 10.1161/01.CIR.96.5.1432, 9315528.
2. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Jr Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22. 10.1056/NEJM199901073400103, 9878640.
3. Matsumoto K, Sera Y, Nakamura H, Ueki Y, Miyake S. Correlation between common carotid arterial wall thickness and ischemic stroke in patients with type 2 diabetes mellitus. Metabolism 2002, 51:244-247. 10.1053/meta.2002.28971, 11833056.
4. Melidonis A, Kyriazis IA, Georgopali A, Zairis M, Lyras A, Lambropoulos T, Matsaidonis D, Foussas S. Prognostic value of the carotid artery intima-media thickness for the presence and severity of coronary artery disease in type 2 diabetic patients. Diabetes Care 2003, 26:3189-3190. 10.2337/diacare.26.11.3189, 14578264.
5. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 1996, 27:1986-1992. 10.1161/01.STR.27.11.1986, 8898803.
6. Goff DC, D'Agostino RB, Haffner SM, Saad MF, Wagenknecht LE. Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2000, 23:1006-1011. 10.2337/diacare.23.7.1006, 10895855.
7. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G. Insulin signalling in osteoblasts integrates bone remodelling and energy metabolism. Cell 2010, 142:296-308. 10.1016/j.cell.2010.06.003, 2910411, 20655470.
8. Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev 2008, 29:441-464. 10.1210/er.2008-0002, 2528848, 18451258.
9. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100:197-207. 10.1016/S0092-8674(00)81558-5, 10660043.
10. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520. 10.1038/nature03398, 15724149.
11. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469. 10.1016/j.cell.2007.05.047, 2013746, 17693256.
12. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008, 105:5266-5270. 10.1073/pnas.0711119105, 2278202, 18362359.
13. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:45-49.
14. Chen L, Li Q, Yang Z, Ye Z, Huang Y, He M, Wen J, Wang X, Lu B, Hu J, Liu C, Ling C, Qu S, Hu R. Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. Diabet Med 2012,
15. Bao Y, Zhou M, Lu Z, Li H, Wang Y, Sun L, Gao M, Wei M, Jia W. Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clin Endocrinol (Oxf) 2011, 75:196-201.
16. D'Agostino RB, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, Saad MF, Bergman RN, Howard G, Wagenknecht L, Haffner SM. Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke 1996, 27:1744-9. 10.1161/01.STR.27.10.1744, 8841322.
17. Wei M, Gonzalez C, Haffner SM, O'Leary DH, Stern MP. Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio, Texas. Association with diabetes and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 1996, 16:1388-92. 10.1161/01.ATV.16.11.1388, 8911278.
18. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2011, 10:72. 10.1186/1475-2840-10-72, 3163178, 21816063.
19. Chen L, Yang Z, Lu B, Li Q, Ye Z, He M, Huang Y, Wang X, Zhang Z, Wen J, Liu C, Qu S, Hu R. Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes. Clin Endocrinol (Oxf) 2011, 75:766-70.
20. Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Hankey GJ, Beilby JP, Norman PE. Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study. Osteoporos Int 2012, 23:599-606. 10.1007/s00198-011-1586-1, 21359669.
21. Targher G, Bertolini L, Padovani R, Zenari L, Scala L, Cigolini M, Arcaro G. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006, 65:593-7.
22. Bzowska M, Nogieć A, Skrzeczyńska-Moncznik J, Mickowska B, Guzik K, Pryjma J. Oxidized LDLs inhibit TLR-induced IL-10 production by monocytes: a new aspect of pathogen-accelerated atherosclerosis. Inflammation 2012, 35:1567-84. 10.1007/s10753-012-9472-3, 3397235, 22556042.
23. Yang Z, Wen J, Tao X, Lu B, Du Y, Wang M, Wang X, Zhang W, Gong W, Ling C, Wu S, Hu R. Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people. Mol Biol Rep 2011, 38:1145-50. 10.1007/s11033-010-0212-1, 20625834.
24. Yang Z, Zhang Z, Wen J, Wang X, Lu B, Yang Z, Zhang W, Wang M, Feng X, Ling C, Wu S, Hu R. Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. J Clin Endocrinol Metab 2010, 95:3926-32. 10.1210/jc.2009-2194, 20501684.
25. Fadini GP, Albiero M, Menegazzo L, Boscaro E, Agostini C, de Kreutzenberg SV, Rattazzi M, Avogaro A. Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp Diabetes Res 2012, 2012:921685. 3299316, 22474430.
26. Fadini GP, Albiero M, Menegazzo L, Boscaro E, Vigili De Kreutzenberg S, Agostini C, Cabrelle A, Binotto G, Rattazzi M, Bertacco E, Bertorelle R, Biasini L, Mion M, Plebani M, Ceolotto G, Angelini A, Castellani C, Menegolo M, Grego F, Dimmeler S, Seeger F, Zeiher A, Tiengo A, Avogaro A. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res 2011, 108:1112-21. 10.1161/CIRCRESAHA.110.234088, 21393578.
27. Muneyuki T, Nakajima K, Aoki A, Yoshida M, Fuchigami H, Munakata H, Ishikawa SE, Sugawara H, Kawakami M, Momomura S, Kakei M. Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults. Cardiovasc Diabetol 2012, 11:80. 10.1186/1475-2840-11-80, 3439247, 22748134.
28. Reyes-Garcia R, Rozas-Moreno P, Jimenez-Moleon JJ, Villoslada MJ, Garcia-Salcedo JA, Santana-Morales S, Muñoz-Torres M. Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes. Diabetes Metab 2012, 38:76-81. 10.1016/j.diabet.2011.07.008, 21996253.
29. Håglin L, Bäckman L, Törnkvist B. A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Cardiovasc Diabetol 2011, 10:116. 10.1186/1475-2840-10-116, 3265426, 22192330.
30. Kanazawa I, Yamaguchi T, Sugimoto T. Relationship between bone biochemical markers versus glucose/lipid metabolism and atherosclerosis; a longitudinal study in type 2 diabetes mellitus. Diabetes Res Clin Pract 2011, 92:393-9. 10.1016/j.diabres.2011.03.015, 21466902.
31. Reinhard H, Nybo M, Hansen PR, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rasmussen LM, Rossing P, Jacobsen PK. Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria. Cardiovasc Diabetol 2011, 10:70. 10.1186/1475-2840-10-70, 3162489, 21801376.
32. Pennisi P, Russo E, Gaudio A, Veca R, D'Amico F, Mangiafico RA, Laspina M, Tringali G, Signorelli SS, Fiore CE. The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role?. Maturitas 2010, 67:358-62. 10.1016/j.maturitas.2010.07.013, 20727694.
33. Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M, Detrano R, Post W, Wong ND. Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:2289-96. 10.1161/ATVBAHA.110.208181, 2959146, 20814018.
34. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001, 21:1998-2003. 10.1161/hq1201.100229, 11742876.
35. Ichijima T, Matsuzaka K, Tonogi M, Yamane GY, Inoue T. Osteogenic differences in cultured rat periosteal cells under hypoxic and normal conditions. Exp Ther Med 2012, 3:165-170. 10.3892/etm.2011.393, 3438792, 22969863.